Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study

BACKGROUND: Key goals in the treatment of CAP include early response to treatment and achievement of clinical stability. The US FDA recommends early response endpoints (72 hours after initiation of treatment) in clinical trials for the treatment of community-acquired bacterial pneumonia. REACH (REtr...

Descripción completa

Detalles Bibliográficos
Autores principales: Blasi, Francesco, Ostermann, Helmut, Racketa, Jill, Medina, Jesús, McBride, Kyle, Garau, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903813/
https://www.ncbi.nlm.nih.gov/pubmed/24450444
http://dx.doi.org/10.1186/1465-9921-15-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903813/
https://www.ncbi.nlm.nih.gov/pubmed/24450444
http://dx.doi.org/10.1186/1465-9921-15-6

Ejemplares similares